3974 Ulrich Abel: Die zytostatische Chemotherapie fortgeschrittener 
epithelialer Tumoren. Hippokrates 1990. ISBN 3-7773-0967-2.
A very critical review of cancer chemotherapy.

21231 Rachel Airley: Cancer chemotherapy. Wiley 2009, 340p. Eur 31.

11465 Wadih Arap/Renata Pasqualini/Erkki Ruoshlahti: Cancer treatment
by targeted drug delivery to tumor vasculature in a mouse model.
Science 16 January 1998, 377-380.

20206 Catherine Arnst: Cancer's cruel economics.
Businessweek 21 May 2008, 6p.

11457 Marcia Barinaga: Peptide-guided cancer drugs show promise in mice.
Science 16 January 1998, 323-324.

Bruce Chabner/Dan Longo (ed.): Cancer chemotherapy and biotherapy - principles
and practice. Lippincott-Raven 1996, 850p. 0-397-51418-2. $133.
The new edition contains chapters on endocrine therapies, antifolates,
5-fluoropyrimidines, cytidine analogues, purine antimetabolites,
hydroxyurea, antimicrotubule agents, alkylating agents, antitumor
antibiotics, anthracyclines, topoisomerase ii inhibitors, enzyme therapy
and anti-HIV drugs.

9284 P. Chiba: Molekulare Grundlagen der Chemotherapieresistenz.
Internet 1996.

9283 M. Clemens/G. Ehninger/H. Waller: Antioxidantien bei Tumorpatienten unter
Chemo- und Strahlentherapie. Internet, ca. 1993.

10355 M. Costa/J. Boldrini: Conflicting objectives in chemotherapy
with drug resistance. Bull. Math. Biol. 59 (1997), 707-724.

14052 Anthony Dear/Robert Medcalf: The novel anti-tumour agent
oxamflatin differentially regulates urokinase and plasminogen
activator inhibitor type 2 expression and inhibits urokinase-mediated
proteolytic ativity. Biochim. Biophysica Acta 1492 (2000), 15-22.

C. Dive/J. Hickman: Drug-target interactions - only the first step
in the commitment to a programmed cell death?
Brit. J. Cancer 64 (1991), 192-...

8984 Steve Dunn: MedLine search on coenzyme Q10 and cancer. Internet 1996.

21596 Marco Eleopra: Novel antitumor agents structurally related
to aminobisphosphonates and stilbenes.
Tesi Dottorato Univ. Ferrara ca. 2007, 130p.

David Fischer/M. Tish Knobf (?)/Henry Durivage: The cancer chemotherapy
handbook. Mosby-Year Book 1997. 0-81513314-6.

Kenneth Foon/Hyman Muss: Biological and hormonal therapies of cancer.
Kluwer 1998. 0-79239997-8.

L. Franks/N. Teich (ed.): Introduction to the cellular and molecular
biology of cancer. Oxford UP 1991.

13156 Jackson Gibbs: Mechanism-based target identification and drug
discovery in cancer research. Science 17 March 2000, 1969-1973.

67 Tullio Giraldi: I farmaci antitumorali. 2 Le Scienze, 59-64.

13368 Trisha Gura: Caution raised about possible new drug.
Science 5 May 2000, 786-787. TRAIL seems to kill normal human liver cells.

21405 Michael Haffner/Chiara Berlato/Wolfgang Doppler: Exploiting
our knowledge of NF-kappaB signaling for the treatment of
mammary cancer. J. Mamm. Gland Biol. Neoplasia 11 (2006), 63-73.

Robert Ignoffo: Cancer chemotherapy pocket guide.
Lippincott-Raven 1997. 0-39751521-9.

6576 Rakesh Jain: Barrieren in Tumoren gegen Therapeutika.
Spektrum 1994/9, 48-55. Fuer krebsbekaempfende Medikamente und auch fuer 
manipulierte Abwehrzellen ist der Zugang zu saemtlichen Zellen einer 
boesartigen Geschwulst auf vielfaeltige Weise erschwert. Dies ist ein Grund, 
warum Mittel, die Krebszellen in Kultur abtoeten, Herde im Koerper oft nicht 
auszumerzen vermoegen.

Rakesh Jain: Transport of molecules across tumor vasculature.
Cancer and Metastasis Review 6/4 (1987), 559-593.

Rakesh Jain: Transport of molecules in the tumor interstitium. A review.
Cancer Research 47/12 (1987), 3039-3051.

Rakesh Jain: Determinants of tumor blood flow. A review. 
Cancer Research 48/10 (1988), 2641-2658.

David Khayat/Gabriel Hortobagyi (ed.): Progress in anti-cancer chemotherapy.
Blackwell 1997. 0-86542564-7.

9787 H. Linskens: Mistelextrakt unterdru''ckt Mitosen.
Mikrokosmos 86 (1997), 168.

21400 Xianghui Ma/Zhiwen Wang: Anticancer drug discovery in the
future - an evolutionary perspective.
Drug Discovery Today 14/23-24 (2009), 1136-1142.

J. Malpas: Chemotherapy. In Franks/Teich 1991, 451-467.

12401 Friedrich Marks/Gerhard Fu''rstenberger: Krebspra''vention mit
Schmerzmitteln. Spektrum 1999/2, 52-60.

I. Pastan/D. Fitzgerald: Recombinant toxins for cancer treatment.
Science 254 (1991), 1173-1177.

272 Terry Priestman: Krebs-Chemiotherapie. Zuckschwerdt 1983.

21407 Fazlul Sarkar/Yiwei Li: Using chemopreventive agents to enhance
the efficacy of cancer therapy. Cancer Res. 66/7 (2006), 3347-3350.

9260 Robert Service: Tumor-killer made; how does it work?
Science 20 December 1996, 2009.

Susan Sturges Hyde: No more bad hair days. A woman's journey through cancer.
Longstreet 1997. 1-56352412-0. $10.

Beverly Teicher: Anticancer drug development guide - preclinincal and
clinical screening and approval.
Humana 1997. 0-89603461-5. $125.

18792 Michael Trieb/.../Klaus Liedl: Cooperative effects on the
formation of intercalation sites. Nucl. Ac. Res. 32/15 (2004), 8p.
Interaction of daunomycin with DNA.

9080 ZZ: Mo''glichkeiten der Chemotherapie.
O''st. Krebshilfe, Internet 1996.

9081 ZZ: Chemotherapie bei Krebserkrankungen.
O''st. Krebshilfe, Internet 1996.

9291 ZZ: Methotrexate sodium injection. Internet, ca. 1996.

9292 ZZ: Novantrone. Internet, ca. 1996.